Lynda G. Balneaves, RN (BC), PhD

Steering Committee

Dr. Balneaves has been a nursing leader in the fields of shared treatment decision making and complementary and integrative health care. She is the Principal Investigator of the Complementary Medicine Education and Outcomes (CAMEO) research program (www.cameoprogram.org) and has published and presented on topics related to knowledge translation, integrative oncology, and treatment decision making. She is currently the President-Elect of the Society for Integrative Oncology (SIO) and serves on the board of the International Society for Complementary Medicine Research (ISCMR). She teaches a graduate level course in evidence-informed practice, co-teaches the palliative care undergraduate course and supervises students interested in the treatment decision-making process, the lived experiences of people affected by cancer, and medical cannabis. Dr. Balneaves has been the recipient of the Canadian Association of Nurses in Oncology Award of Excellence in Nursing Research and the Award of Excellence in Research from the College of Registered Nurses of British Columbia.


Paul Daeninck, MD MSc FRCPC

Steering Committee

Dr. Paul Daeninck is a medical oncologist and palliative medicine consultant with CancerCare Manitoba and the Winnipeg Regional Health Authority (WRHA) Palliative Care Program. He is the Site Coordinator at the St. Boniface Hospital, and Chair of the Symptom Management and Palliative Care Disease Site at CancerCare Manitoba. He is an Assistant Professor and Leader for the Palliative Care Longitudinal Theme at the Medical School of the University of Manitoba.

Dr. Daeninck has served with several national organizations, including those of the Royal College and Canadian Partnership Against Cancer. He sits on the Board of Directors of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), and is currently a member of the Board of Directors for the Canadian Society of Palliative Care Physicians.

Dr. Daeninck is the author of several research papers and textbook chapters and serves as a reviewer for palliative medicine journals. He has been active in medical student and resident education, and has ongoing research interests in several aspects of palliative medicine.

Dr. Matthew Hill, PhD

Steering Committee

Matthew Hill is an Assistant Professor in the Departments of Cell Biology and Anatomy and Psychiatry at the Hotchkiss Brain Institute at the University of Calgary (Canada). He was trained in Behavioral Neuroscience and Psychoneuroendocrinology at the University of British Columbia and did postdoctoral training in the laboratory of Dr. Bruce McEwen at the Rockefeller University. Dr. Hill’s research has helped to reveal the critical role, and neural circuits through which, endocannabinoid signaling regulates acute responsiveness and adaptation of the stress response, both at the neuroendocrine and behavioral level. Further, his research has demonstrated how chronic stress can compromise endocannabinoid function, identifying this system as target for both the pathophysiology and treatment of stress-related mood and anxiety disorders.


Bernard Le Foll, MD, PhD, MCFP

Steering Committee Co-Chair

Dr. Le Foll is a Laureate of the French Academy of Medicine, Medical Head, Addiction Medicine Service and Medical Withdrawal Service, Ambulatory Care and Structured Treatments, CAMH; Head, Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments, CAMH. Head,Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, CAMH. Professor, Departments of Family and Community Medicine, Pharmacology, Psychiatry and Institute of Medical Sciences; University of Toronto.

Dr. Le Foll is a clinician-scientist specialized in drug addiction. The mail goal of his research is to improve treatment of drug addiction. For this purpose, various approaches are used such as clinical trials, preclinical models, genetic and brain imaging approaches. The goal is to develop novel therapeutic strategies in clinical populations. There is a large interest around pharmacotherapies for alcohol dependence treatment and for other addictive behaviors and how to optomize pharmacotherapies interventions.


Colleen O’Connell, MD FRCPC

Steering Committee

Following a chemistry degree at St. Francis Xavier University Colleen completed medical school at Memorial University of Newfoundland and residency in Physical Medicine & Rehabilitation at Dalhousie University. She specializes in neurorehabilitation and is Research Chief at the Stan Cassidy Centre for Rehabilitation in New Brunswick, Canada, with faculty appointments at both Memorial and Dalhousie University Faculty of Medicine and University of New Brunswick Faculty of Graduate Studies. She is a member of the Canadian ALS Clinical Trials and Research Network, The Rick Hansen Institute Research Network, the Atlantic Mobility Action Project, and represents Canada on the board of the International Society of Physical and Rehabilitation medicine.

Over the past decade, Colleen has led the Stan Cassidy Centre in growing its research capacity through participation in national and international clinical trials, and building applied research partnerships with University of New Brunswick’s Institute for Biomedical Engineering, with collaborations on projects for evaluating biometric markers such as strength, movement and tone in persons affected by neurological injuries. A strong patient advocate, she helped develop New Brunswick’s Ventilation Program, and the Canadian Thoracic Society’s Clinical Practice Guideline for Home Mechanical Ventilation. She has conducted numerous workshops and lectures on topics of neuromuscular disease management, including pain, spasticity, sexuality, and respiratory care, and has been recognized with the 2012 Atlantic Muscular Dystrophy Association George Carpati Award, the 2010 ALS Canada Tony Proudfoot Award for Education Programs, the 2012 YMCA Peace Medallion, and the 2012 Federation of Medical Women of Canada Honorary Member.

In addition to her clinical and research practice, Colleen is founder and chair of Team Canada Healing Hands, a not-for-profit organization dedicated to advancing rehabilitation care and training in developing countries. She has been leading teams of health care professionals and support volunteers on global outreach initiatives in areas of care delivery, training, and research. She was a member of Handicap International’s emergency response team in the 2010 Haiti earthquake. She is co-chair of the CAPM&R Special Interest Group on International Health, is a member of the Disaster Committees of the International Spinal Cord Society and ISPRM. She has co-authored numerous publications on disaster, including issues of amputation and spinal cord injury in the humanitarian field. She resides in Keswick Ridge, New Brunswick, with her husband Jeff Campbell, her two Haitian-born boys Samuel and Vénel, and a collection of cats and dogs. When not at work or overseas, she can usually be found in a hockey rink, complaining about the cold.


Danial Schecter, MD, CCFP

Steering Committee

Dr. Danial Schecter is co-founder of the Cannabinoid Medical Clinic and a practicing family physician. After working along side some of Canada’s leading researchers in the field of medical marijuana, Dr. Schecter developed a strong interest in the therapeutic use of cannabinoids. In addition to cannabinoid medicine, Dr. Schecter’s clinical interests include delivering a high standard of care to at risk elderly and palliative care patients, prompting him to establish his own house-calls service in Georgian Bay, ON. Dr. Schecter completed a fellowship in Hospital Medicine and is an active hospitalist at the Royal Victoria Regional Health Centre in Barrie, ON.


Beth Sproule, RPh, BScPhm, PharmD

Steering Committee

Dr. Beth Sproule is an Advanced Practice Pharmacist and a Clinician-Scientist at the Centre for Addiction and Mental Health. She is also Assistant Professor in the Faculty of Pharmacy and the Department of Psychiatry at the University of Toronto.



Mark A. Ware, MBBS MRCP(UK) MSc

Steering Committee Co-Chair

Associate Professor of Anesthesia and Family Medicine, McGill University, Director of Clinical Research, Alan Edwards Pain Management Unit, Montreal General Hospital.

Mark Ware is a family physician and Associate Professor in Family Medicine and Anesthesia at McGill University. He is the Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre, co-Director of the Quebec Pain Research Network, and Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids. He practices pain medicine at the Montreal General Hospital.

Dr Ware’s primary research interests are in evaluating the safety and effectiveness of medicines derived from cannabis (cannabinoids), population-based studies of the impact of pain on the population, and complementary therapies in pain and symptom management. His research is funded by the FRSQ, CIHR, and the Louise and Alan Edwards Foundation, as well as grants from pharmaceutical companies.